FDA Import Refusal SCS-0775258-3/10003/1 — Abbvie Corporation
The FDA refused shipment SCS-0775258-3/10003/1 from Abbvie Corporation (Canada) on Jan 14, 2026. The refused product falls under Drugs and Biologics — RISANKIZUMAB-RZAA. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jan 14, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58MCY09 RISANKIZUMAB-RZAA
- Charges
- 75